Boston, Massachusetts, United States In 1982 was created The Baupost Group, which is appeared as VC. The company was established in North America in United States. The main office of represented VC is situated in the Boston.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the The Baupost Group, startups are often financed by Omega Funds, SR One, New Leaf Venture Partners. The meaningful sponsors for the fund in investment in the same round are Omega Funds, Fidelity Management and Research Company, SR One. In the next rounds fund is usually obtained by Omega Funds, Fidelity Management and Research Company, Silicon Valley Bank.
The usual things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 deals per year. Comparing to the other companies, this The Baupost Group performs on 28 percentage points more the average number of lead investments. The top activity for fund was in 2014. The real fund results show that this VC is 23 percentage points more often commits exit comparing to other companies. The top amount of exits for fund were in 2019. The average startup value when the investment from The Baupost Group is more than 1 billion dollars.
The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Intarcia Therapeutics, Idenix Pharmaceuticals, Gossamer Bio. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Personal Health, Biotechnology.
We also calculated 7 valuable employees in our database.
Related Funds
| Fund Name | Location |
| Beril AG | - |
| Books on Demand | Canfield, Ohio, United States |
| Central Piedmont Investment Group | - |
| GRE Capital | - |
| Hejun Capital | Beijing, Beijing, China |
| Jingu Zichan | China, Guangdong, Shenzhen |
| Jingxin Venture Capital | - |
| Lakson Investments Venture Capital | Karachi, Pakistan, Sindh |
| Lendingkart | Ahmedabad, Gujarat, India |
| Pivotal Capital | California, Menlo Park, United States |
| Sallfort Privatbank AG | Basel, Basel-Stadt, Switzerland |
| Scion Capital | - |
| Senvest Management | New York, New York, United States |
| Shore Ventures II | - |
| Stakeboat Capital | Bengaluru, India, Karnataka |
| TMCT Ventures | California, Santa Monica, United States |
| W2 Labs | England, London, United Kingdom |
| Wolfswood Partners | New York, New York, United States |
| Z80 Labs Technology Incubator | Buffalo, New York, United States |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Cellarity | $123M | 25 Feb 2021 | Cambridge, Massachusetts, United States | ||
Cullinan Oncology | $131M | 17 Dec 2020 | Cambridge, Massachusetts, United States | ||
BOPU | $20M | 01 Sep 2020 | Boston, Massachusetts, United States | ||
Nuvation Bio | $275M | 28 Oct 2019 | New York, New York, United States | ||
帆船 | $3M | 03 Sep 2019 | - | ||
Wren Therapeutics | $24M | 22 Jan 2019 | Cambridge, England, United Kingdom | ||
Gossamer Bio | $230M | 23 Jul 2018 | San Diego, California, United States | ||
Translate Bio | $42M | 01 Dec 2017 | Cambridge, Massachusetts, United States | ||
Translate Bio | $51M | 10 Jan 2017 | Cambridge, Massachusetts, United States |
– Outbrain, an adtech company, raised $200m funding.
– The round was led by Baupost Group.
– Outbrain filed for an IPO last week.
– Ro Raises $500 Million in Series D Funding to Expand its Vertically Integrated Primary Care Platform
– Ro is the healthcare technology company
– The company has completed a $500 million Series D fundraising round led by existing investors General Catalyst, FirstMark Capital and TQ Ventures, with significant participation from existing investors SignalFire, Torch Capital and BoxGroup as well as new investors Altimeter Capital, Baupost Group, Dragoneer Investment Group, ShawSpring Partners, Radcliff, and 776.
– The Series D brings Ro’s total fundraising since its founding in 2017 to $876 million.
– Ro will use the newly-raised capital to strengthen its vertically integrated primary care platform.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Cellarity | $123M | 25 Feb 2021 | Cambridge, Massachusetts, United States | ||
Cullinan Oncology | $131M | 17 Dec 2020 | Cambridge, Massachusetts, United States | ||
BOPU | $20M | 01 Sep 2020 | Boston, Massachusetts, United States | ||
Nuvation Bio | $275M | 28 Oct 2019 | New York, New York, United States | ||
帆船 | $3M | 03 Sep 2019 | - | ||
Wren Therapeutics | $24M | 22 Jan 2019 | Cambridge, England, United Kingdom | ||
Gossamer Bio | $230M | 23 Jul 2018 | San Diego, California, United States | ||
Translate Bio | $42M | 01 Dec 2017 | Cambridge, Massachusetts, United States | ||
Translate Bio | $51M | 10 Jan 2017 | Cambridge, Massachusetts, United States |
